| Literature DB >> 26793474 |
Alessandra Vergori1, Alfonso Cerase2, Lucia Migliorini1, Maria Grazia Pluchino3, Giuseppe Oliveri3, Umberto Arrigucci2, Andrea De Luca4, Francesca Montagnani4.
Abstract
Spinal epidural abscesses (SEAs) are unusual bacterial infections, with possible devastating neurologic sequelae. Despite abundance of case series in adults, reports in children are scanty. We describe a spontaneous SEA due to methicillin susceptible Staphylococcus aureus (MSSA) in a previously healthy 15-year old male, and we perform a literature review regarding management of pediatric SEAs without risk factors, from 2001 to 2014. We found a total of 12 cases (8 males, average age 9.6 years). Clinical presentation was mainly fever, back pain and elevation of inflammation markers. All cases were initially misdiagnosed. Lumbar puncture was performed in 36% of patients. Etiological diagnosis was obtained in 8 cases. MSSA was isolated in 4 patients, methicillin-resistant S. aureus in 1 patient, and S. aureus with unknown susceptibility patterns in 2 cases. The average of therapy duration was 6 weeks. Patients' spine was always evaluated by gadolinium-enhanced magnetic resonance imaging; most abscesses were localized at thoracic and lumbar area, without osteomyelitis. In 8 cases, laminectomy and/or abscess drainage were performed in association with medical therapy; 3 cases were successfully treated with antimicrobial therapy only; no data were available in one case. A good outcome was obtained in all patients, except a reported residual headache and paraspinal pain lasting for 3 years. The rarity and the possible differential diagnosis can lead to underestimate SEA occurrence in children without risk factors. It seems therefore essential to maintain a high attention to pediatric SEAs. A prompt diagnosis and adequate therapy are essential prognostic factors for remission.Entities:
Keywords: Children; Management; Spinal epidural abscess; Staphylococcus aureus
Year: 2015 PMID: 26793474 PMCID: PMC4712210 DOI: 10.1016/j.idcr.2015.09.008
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Fig. 1Magnetic resonance imaging of the thoraco-lumbar spine at diagnosis: unenhanced T2-weighted (a), short tau inversion recovery (STIR) (b), diffusion-weighted (DW) (c), apparent diffusion coefficient (ADC) map (d), and T1-weighted (e) sagittal and T2-weighted axial (g) images, and gadolinium-enhanced T1-weighted sagittal (f) and axial (h) images. At the thoracolumbar junction, a posterior median-left paramedian epidural collection compressing the caudal spinal cord, conus medullaris, and upper cauda equina is clearly evident. The lesion shows irregular signal intensity on unenhanced conventional sequences (a, b, and e, black arrows), restricted diffusion on DW images and ADC map (c, d, white arrows), and peripheral gadolinium-enhancement (f, h). Note also that the lesion shows extent toward the left intervertebral foramen (g, h, arrow head). STIR image does not show associated abnormal signal intensity of the bone marrow.
Fig. 2Magnetic resonance imaging follow-up by STIR (upper line) and gadolinium-enhanced fat-suppressed T1-weighted (lower line) sagittal images obtained 24 days after surgery (a) and one month (b), three months (c), and seven months (d) later. Besides complete removal and absence of relapse of the epidural abscess, a clearcut reduction of gadolinium-enhancing reactive changes is evident. Note also the progressive development of kyphosis with fulcrum at L1–L2 level, together with increase of lumbar lordosis.
Clinical, instrumental and laboratoristic findings in the reviewed SEAs cases.
| Patient | Year of study | Gender, age | Spine level | Location | Symptoms at admission | Primary | CSF | WBC/mmc | CRP Level | Positive blood culture |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2001 | F, 7 weeks | T10–12 | N/A | Flaccid paraplegia | N/A | N/P | Normal | Normal | N/A |
| 2 | 2011 | M, 15 years | T3–T8 | Right Postero-lateral | Right scapular pain, fever, chills with night sweats, headache, photophobia | Right rhomboid muscle strain with spasm, acute febrile illness | Normal | N/A | 84.5 mg/L (n.v. <10) | Yes |
| 3 | 2011 | F, 11 years | T11–L4 | Posterior | Fever, lumbar pain | Back pain | N/P | 13,770 (82%) | 27.2 mg/dl (n.v. <0.5) | No |
| 4 | 2012 | M, 16 days | C1/2 – lumbosacral | Posterior+ | Fever, nervousness | N/A | 180 PMN, 9900 red blood cells | 21,200 (43%) | 232 g/L (n.v. N/A) | Yes |
| 5 | 2012 | M, 15 years | L2–L3 | Posterior | Urinary retention, Backpain, Fever | Low back pain and Not specified urinary retention | N/P | 18,600 (70%) | ++ (value N/A) | N/A |
| 6 | 2013 | M, 13 years | C7–T1 | Posterior, on both sides | Transient fever, neck and upper back pain, tingling sensation in hands and feet, urine incontinence, abdominal distension, inability to sit and walk | Acute myelitis, diskitis, meningitis | 800 cells/mmc, 2% PMN, glucose 21 mg/dl | 7,100 (N/A) | ++ (value N/A) | No |
| 7 | 2013 | M, 1.2 years | L3–L4 | Posterior | Refusal to walk, irritability, weakness | N/A | N/P | 13,800 (N/A) | N/A | No |
| 8 | 2013 | M, 3 years | T1–L2 | Posterior | Fever, stomachache | N/A | N/P | 20,000 (N/A) | 82.2 mg/L | Yes |
| 9 | 2013 | F, 17 years | L1–L4 | Posterior | Fever, nausea, vomiting | N/A | N/P | 15,800 (N/A) | 182 mg/L | No |
| 10 | 2013 [Present report] | M, 15 years | T11–L2 | Left and posterior | Fever, headache, back pain | Meningitis, myelitis | 138 cells/mmc, 67% PMN, glucose 67 mg/dl, proteins 145.30 mg/dl | 11,300 (86.3%) | 10.20 mg/dl (n.v. <0.5) | No |
| 11 | 2014 | M, 21 months | L4–L5 | Right into the spinal canal | Fever, refuse to walk | Septic arthritis | N/P | N/A | 200.1 mg/L | No |
N/A, not available.
CRP, C-reactive protein; n.v., normal value.
CSF, cerebrospinal fluid; N/P, lumbar puncture not performed.
Etiology, therapy and outcome in the reviewed SEAs cases.
| Patient | Year of study | Etiology | Source of isolate | Osteomyelitis | Surgery | Empiric therapy | Targeted therapy | Duration of therapy | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2001 | Pus | Absent | T9–T12 laminectomy | N/A | Not specified iv anti- | N/A | No deficit after 18 months follow up | |
| 2 | 2011 | MSSA | Blood | Absent | Thoracic laminectomy-drainage | Cefotaxime | Ceftriaxone | 4 weeks | Residual headache and paraspinal pain for subsequent 3 years |
| 3 | 2011 | MSSA | Pus | Absent | Drainage | Vancomycin + Ceftriaxone | Clindamycin+ | 7.5 weeks | No deficit |
| 4 | 2012 | MSSA | Pus and Blood | Absent | Right sided laminectomy drainage | Ampicillin + Gentamicin Then | Flucloxacillin + Ampicillin | 8 weeks | No deficit |
| 5 | 2012 | Pus | N/A | L2–L3 laminectomy drainage | N/A | Cefazolin | 6 weeks | No deficit | |
| 6 | 2013 | Unknown | – | Absent | None | Ceftriaxone + Vancomycin | N/A | 6 weeks | No deficit |
| 7 | 2013 | Unknown | – | Absent | None | Nafcillin, Vancomycin | N/A | N/A | Standing with assistance on discharge |
| 8 | 2013 | MRSA | Blood | Absent | Left laminectomy T5–L2 | Clindamycin iv+ | Clindamycin | N/A | No deficit |
| 9 | 2013 | Unknown | – | Absent | None | Daptomycin iv+ | N/A | N/A | No deficit |
| 10 | 2013 [Present report] | MSSA | Pus | Absent | L2 Laminectomy-abscess drainage | Vancomycin + meropenem | Ceftriaxone + Clindamycin iv, Then amoxicillin/clavulanate + rifampicin | 8 months | No deficit |
| 11 | 2014 | Group A beta-hemolytic | Pus | Absent | L4–L5, | N/A | 6 weeks | No deficit |
MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin resistant Staphylococcus aureus; where not specified: not reported.
N/A, Not available.